Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome

Int J Hematol. 2021 Jun;113(6):775-776. doi: 10.1007/s12185-021-03147-1. Epub 2021 Apr 17.

Authors

Kensuke Narukawa¹, Akiko Masuda¹, Tsuyoshi Takahashi²

Affiliations

¹ Division of Hematology, Mitsui Memorial Hospital, 1 Kanda Izumicho, Chiyoda-ku, Tokyo, 101-8043, Japan.
² Division of Hematology, Mitsui Memorial Hospital, 1 Kanda Izumicho, Chiyoda-ku, Tokyo, 101-8043, Japan. tsu-tky@umin.net.

PMID: 33864622
DOI: 10.1007/s12185-021-03147-1

No abstract available

Keywords: Erythropoietin; Myelodysplastic syndrome; Pure erythroid leukemia.

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Bone Marrow / pathology*
Erythroblasts / pathology*
Erythropoiesis*
Erythropoietin / blood*
Humans
Male
Myelodysplastic Syndromes / blood
Myelodysplastic Syndromes / diagnosis
Myelodysplastic Syndromes / pathology*

Substances

EPO protein, human
Erythropoietin